Tirzepatide

Dual GIP / GLP-1 receptor agonist

FDA-approved tirzepatide products may be prescribed for specific diabetes or chronic weight-management indications. Eligibility, contraindications, titration, and monitoring require a licensed prescriber.

Book consultation (845) 285-1633

Treatment details

What’s included

Clinical consultation, medical-history and medication review, eligibility assessment, discussion of regulatory status and alternatives, and ongoing monitoring when appropriate.

Clinical & Availability Review

Office: 2874 Route 94, Washingtonville, NY 10992

Appointments

Monday through Saturday from 1:00 PM to 6:00 PM.

Mobile infusion appointments are available Monday through Saturday from 9:00 AM to 8:00 PM.

Continue to booking PAYMENTS PLANS AVAILABLE

Explore more

Related peptide options

Prescription

Semaglutide

FDA-approved semaglutide products are prescribed for specific indications, including type 2 diabetes or chronic we...

View option

Research Only

Retatrutide

Retatrutide is investigational and is not FDA-approved. FDA states that it cannot be used in compounding under fed...

View option